A new study of Medicare payments has found that over a five-year period, the payments for medications prescribed to people with neurologic conditions like multiple sclerosis (MS), Parkinson’s disease and epilepsy increased by 50% while the number of claims for these prescription medications only rose by only 8%. The study is published in the online issue of Neurology®, the medical journal of the American Academy of Neurology. The study, funded by the American Academy of Neurology, also found that most of the increase was due to rising costs for neuroimmunology drugs, mostly for multiple sclerosis.
SOP Communications
The Colorado Sun
CU Anschutz
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045